Rhenman & Partners Asset Management AB

**Rhenman & Partners Asset Management AB** manages $1.1B across a portfolio of 94 positions, exhibiting a concentrated, large-cap focus. The firm's top holdings are heavily weighted toward the healthcare and biotechnology sectors, notably featuring REGN ($47.4M) and LLY ($45.4M). Significant allocations are also maintained in BSX ($41.1M), MDT ($28.4M), and ISRG ($27.2M). This structure indicates a deep conviction in established, sector-leading pharmaceutical and medical technology names.

📌 Top Holdings